EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery

Yunze Dong, Jun Luo, Mingliang Pei, Shuai Liu, Yuchen Gao, Hongmin Zhou, Yimingniyizi Nueraihemaiti, Xiangcheng Zhan, Tiancheng Xie, Xudong Yao, Xin Guan, Yunfei Xu iD

Advanced Science · 2024

DOI: 10.1002/advs.202308734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yunze Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, P. R. China. Hauptthemen laut MEDLINE: Hydrogels, Neoplasm Recurrence, Local, Disease Models, Animal, Carcinoma, Renal Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Hongkou District Clinical Medicine Talent Training Program, Shanghai Fourth People's Hospital talent promotion program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The unique physical tumor microenvironment (TME) and aberrant immune metabolic status are two obstacles that must be overcome in cancer immunotherapy to improve clinical outcomes. Here, an in situ mechano‐immunometabolic therapy involving the injection of a biomimetic hydrogel is presented with sequential release of the anti‐fibrotic agent pirfenidone, which softens the stiff extracellular matrix, and small interfering RNA IDO1, which disrupts kynurenine‐mediated immunosuppressive metabolic pathways, together with the multi‐kinase inhibitor sorafenib, which induces immunogenic cell death. This combination synergistically augmented tumor immunogenicity and induced anti‐tumor immunity. In mouse models of clear cell renal cell carcinoma, a single‐dose peritumoral injection of a biomimetic hydrogel facilitated the perioperative TME toward a more immunostimulatory landscape, which prevented tumor relapse post‐surgery and prolonged mouse survival. Additionally, the systemic anti‐tumor surveillance effect induced by local treatment decreased lung metastasis by inhibiting epithelial‐mesenchymal transition conversion. The versatile localized mechano‐immunometabolic therapy can serve as a universal strategy for conferring efficient tumoricidal immunity in “cold” tumor postoperative interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsNeoplasm Recurrence, LocalDisease Models, AnimalCarcinoma, Renal CellKidney NeoplasmsTumor MicroenvironmentAnimalsMiceImmunotherapyHumansBiomimeticsSorafenibCell Line, TumorPyridones

Stichwörter der Autor:innen

clear cell renal cell carcinomaimmunometabolic therapyindoleamine 2,3‐dioxygenase 1tumor physical microenvironmenttumor recurrence

Substanzen

HydrogelspirfenidoneSorafenibPyridones

Autor:innen und Institutionen

  • Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, P. R. China.
  • Department of Urology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, P. R. China.
  • Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of…
  • Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.

ORCID-Profile: Yunfei Xu

Förderung

  • National Natural Science Foundation of China
  • Shanghai Hongkou District Clinical Medicine Talent Training Program
  • Shanghai Fourth People's Hospital talent promotion program
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Dong, Y., Luo, J., Pei, M., Liu, S., Gao, Y., Zhou, H., Nueraihemaiti, Y., Zhan, X., Xie, T., Yao, X., Guan, X., & Xu, Y. (2024). Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery. Advanced Science. https://doi.org/10.1002/advs.202308734

Vancouver

Dong Y, Luo J, Pei M, Liu S, Gao Y, Zhou H, et al. Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery. Advanced Science. 2024. doi:10.1002/advs.202308734

BibTeX
@article{Dong2024,
  author = {Dong, Yunze and Luo, Jun and Pei, Mingliang and Liu, Shuai and Gao, Yuchen and Zhou, Hongmin and Nueraihemaiti, Yimingniyizi and Zhan, Xiangcheng and Xie, Tiancheng and Yao, Xudong and Guan, Xin and Xu, Yunfei},
  title = {Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202308734}
}
Kostenlos starten →